ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1161

Synovial Th9 Cells Prolong Neutrophil Survival and Functionally Enhance the Infiltrating T Cells in Rheumatoid Arthritis

Dipendra Kumar Mitra1 and Kaustav Chowdhury2, 1Transplant Immunology & Immunogenetics, All India Institute of Medical Sciences, Delhi, India, 2TRANSPLANT IMMUNOLOGY AND IMMUNOGENETICS, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, New Delhi, India

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: cytokines

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Th-9 cells are distinct T cell subset secreting IL-9 and associated with allergic and parasitic diseases and produced by Th9 cells. Contribution of these cells autoimmune colitis (1, 2), uveitis (3) and experimental autoimmune encephalomyelitis (EAE) has ben reported recently. However, reports on their presence or enrichment at the pathologic sites and impact on the local inflammatory cascade in rheumatoid arthritis (RA) remain unknown. Functional relevance of newly described IL-9 producing CD4+ T cells is not yet been clearly described in RA. This study is an attempt to determine the status of Th9 cells in the disease site in RA patients. Here for the first time, we show that Th9 cells or IL-9 can modulate survival of neutrophils and T cell function and enhances the local inflammatory cascade in RA inflicted joints.

Methods: We recruited treatment naïve active RA patients (n=26) with DAS28-ESR >3.5. Polymorphonuclear (PMNs/Neutrophil) and mononuclear cells (MNCs) were isolated both from the peripheral blood (PBL) and synovial fluid (SF). Neutrophils were cultured in presence of recombinant IL-9 (rIL-9), synovial fluid of RA patients (RA SF), IL-9 neutralizing antibody (aIL-9). MNCs were cultured with plate bound anti-CD3 & anti-CD28 along with rIL-9, RA SF, aIL-9. To easure apoptosis neutrophils were stained for Annexin V and their lysate was immunobloted for expression of anti-apoptotic protein MCL-1. MNCs were stained with CD4 and IL-9 to determine the frequency and function of Th9 cells. Frequencies of other cytokine (IFN-γ, TNF-α, IL-17) producing CD4+ T cells were evaluated by intracellular cytokine staining. 

Results: Significant enrichment of Th9 cell was noted in synovial fluid (SF) of RA patients. Recombinant IL-9 (rIL-9) and RA SF reduced the spontaneous apoptosis of neutrophils along with higher expression of survival protein MCL-1. Blocking endogenous IL-9 of SF decreased their survival and rescued their apoptosis, suggesting the critical role of IL-9 in prolonged neutrophil survival in RA. IL-9 and RA SF also increased the frequencies of TNF-α+, IFN-γ+, IL-17+ CD4+ T cells. Interestingly, both synovial and peripheral Th9 cell frequency showed significant correlation with disease activity DAS-28 ESR score. 

Conclusion: Th9 cells or IL-9 plausibly mediate synovial inflammation by prolonging the neutrophil survival and enhancing inflammatory cytokine producing T cells in the RA joint. So blocking IL-9 by specific antibody could be a possible therapy in RA. Frequency of Th9 cell may serve as objective disease severity biomarker for joint inflammation in RA patients


Disclosure: D. K. Mitra, None; K. Chowdhury, None.

To cite this abstract in AMA style:

Mitra DK, Chowdhury K. Synovial Th9 Cells Prolong Neutrophil Survival and Functionally Enhance the Infiltrating T Cells in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/synovial-th9-cells-prolong-neutrophil-survival-and-functionally-enhance-the-infiltrating-t-cells-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-th9-cells-prolong-neutrophil-survival-and-functionally-enhance-the-infiltrating-t-cells-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology